Regeneron Pharmaceuticals, Inc. (REGN)
NASDAQ · Healthcare
Regeneron Pharmaceuticals, Inc. Revenue 2008–2025
Regeneron Pharmaceuticals, Inc. annual/quarterly revenue history and growth rate from 2008 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Regeneron Pharmaceuticals, Inc. revenue for the quarter ending March 31, 2026 was 3.6 B, a 19.04% increase year-over-year.
- Regeneron Pharmaceuticals, Inc. revenue for the twelve months ending March 31, 2026 was 14.1 B, a 2.09% increase year-over-year.
- Regeneron Pharmaceuticals, Inc. annual revenue for 2025 was 14.3 B, a 0.99% increase from 2024.
- Regeneron Pharmaceuticals, Inc. annual revenue for 2024 was 14.2 B, a 8.27% increase from 2023.
- Regeneron Pharmaceuticals, Inc. annual revenue for 2023 was 13.1 B, a 7.76% increase from 2022.
- Regeneron Pharmaceuticals, Inc. annual revenue for 2022 was 12.2 B.
Revenue
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Regeneron Pharmaceuticals Inc. Market Cap — FAQ
Regeneron Pharmaceuticals Inc. (REGN) market cap over the last 18 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see REGN's market cap history?
The chart and table above show Regeneron Pharmaceuticals Inc.'s market cap by year and by quarter, including the growth rate.